Dipeptidyl peptidase-4 inhibitors and osteoporosis

被引:8
|
作者
Lee, Wen-Ling [1 ,2 ,3 ]
Lee, Fa-Kung [4 ,5 ]
Wang, Peng-Hui [2 ,5 ,6 ,7 ]
机构
[1] Cheng Hsin Gen Hosp, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Inst Clin Med, Taipei, Taiwan
[3] Oriental Inst Technol, Dept Nursing, New Taipei, Taiwan
[4] Cathay Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan
[5] Female Canc Fdn, Taipei, Taiwan
[6] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, 201,Sect 2,Shi Pai Rd, Taipei 112, Taiwan
[7] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan
关键词
RISK; NATIONWIDE; OUTCOMES; CARE;
D O I
10.1097/JCMA.0000000000000775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:889 / 890
页数:2
相关论文
共 50 条
  • [31] The role of dipeptidyl peptidase-4 inhibitors in diabetic kidney disease
    Panchapakesan, Usha
    Pollock, Carol
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [32] Dipeptidyl Peptidase-4 Inhibitors and Heart Failure Risk Analysis
    Vardarli, I.
    Ozcelik, C.
    KARDIOLOGE, 2014, 8 (06): : 448 - 450
  • [33] Cardiovascular safety of dipeptidyl peptidase-4 (DPP-4) inhibitors
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2015, 4 : 19 - 24
  • [34] Determination of Dipeptidyl Peptidase-4 Inhibitors by Spectrophotometric and Chromatographic Methods
    P. B. Deshpande
    S. R. Butle
    Journal of Analytical Chemistry, 2018, 73 : 303 - 316
  • [35] Dipeptidyl Peptidase-4 Inhibitors in the Elderly: More Benefits or Risks?
    Giuseppe Paolisso
    Matteo Monami
    Raffaele Marfella
    Maria Rosaria Rizzo
    Edoardo Mannucci
    Advances in Therapy, 2012, 29 : 218 - 233
  • [36] URATE-LOWERING EFFECTS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS
    Panevin, Taras S.
    Zhelyabina, Olga, V
    Eliseev, Maxim S.
    Shestakova, Marina, V
    DIABETES MELLITUS, 2020, 23 (04): : 349 - 356
  • [37] Can dipeptidyl peptidase-4 inhibitors treat cognitive disorders?
    Cheng, Qi
    Cheng, Jinluo
    Cordato, Dennis
    Gao, Jianqun
    PHARMACOLOGY & THERAPEUTICS, 2020, 212
  • [38] Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis
    Scheen, Andre
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 545 - 557
  • [39] Determination of Dipeptidyl Peptidase-4 Inhibitors by Spectrophotometric and Chromatographic Methods
    Deshpande, P.B. (padmanabh77@yahoo.co.in), 1600, Pleiades journals (73):
  • [40] Dipeptidyl peptidase-4 inhibitors and cardiovascular outcomes: decongesting the matter
    Vaduganathan, Muthiah
    Bhatt, Deepak L.
    EUROPEAN HEART JOURNAL, 2015, 36 (24) : 1497 - 1498